Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Solid Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00785941
What this trial is testing

IMC-A12 Every 2 Weeks in Patients With Tumors Who No Longer Respond to Treatment or No Treatment is Available

Who this might be right for
Advanced Solid Tumors
Eli Lilly and Company 16
Early research (Phase 1)Study completedNCT01212341
What this trial is testing

Allogeneic Natural Killer (NK) Cell Therapy in Patients With Lymphoma or Solid Tumor

Who this might be right for
Malignant LymphomasSolid Tumors
Seoul National University Hospital 18
Early research (Phase 1)Looking for participantsNCT06484556
What this trial is testing

T Cell Receptor Gene-Engineered T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid Tumor

Who this might be right for
Tumor, Solid
Tao Zhang 9
Not applicableStudy completedNCT02724488
What this trial is testing

Selection Pressure and Evolution Induced by Immune Checkpoint Inhibitors and Other Immunologic Therapies

Who this might be right for
Head and Neck CancerMelanoma
University Health Network, Toronto 14
Early research (Phase 1)Study completedNCT01988896
What this trial is testing

Study of Atezolizumab in Combination With Cobimetinib in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumors
Hoffmann-La Roche 153
Early research (Phase 1)Study completedNCT04577703
What this trial is testing

First-In-Human Phase I Trial of Ningetinib ( CT053PTSA ) in the Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Sunshine Lake Pharma Co., Ltd. 20
Not applicableLooking for participantsNCT07676461
What this trial is testing

Oral, Fecal and Intratumoral Microbiome Atlas in Colombian Patients With Advanced Solid Tumors Receiving First-Line Immunotherapy

Who this might be right for
Gastric CancerColorectal CancerBreast Cancer+2 more
Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo 150
Early research (Phase 1)UnknownNCT02897986
What this trial is testing

Study of a Propranolol (HEMANGIOL®) and Oral Metronomic Vinorelbine (NAVELBINE®) Combination for Children and Teenagers With Refractory/Relapsing Solid Tumors

Who this might be right for
Pediatric Cancer
Assistance Publique Hopitaux De Marseille 54
Early research (Phase 1)Study completedNCT00033241
What this trial is testing

Erlotinib Combined With Gemcitabine in Treating Patients With Newly Diagnosed Locally Advanced or Metastatic Pancreatic Cancer or Other Solid Tumors

Who this might be right for
Pancreatic CancerUnspecified Adult Solid Tumor, Protocol Specific
OSI Pharmaceuticals
Early research (Phase 1)Ended earlyNCT06130254
What this trial is testing

Phase Ib Trial of the KRAS G12C Inhibitor Adagrasib (MRTX849) in Combination With the PARP Inhibitor Olaparib in Patients With KRAS G12C Mutated Advanced Solid Tumors, With a Focus on Gynecological, Breast, Pancreatic and KEAP1 Mutated Non-small Cell Lung Cancers

Who this might be right for
Advanced Solid TumorNon-small Cell Lung Cancers
M.D. Anderson Cancer Center 1
Early research (Phase 1)Looking for participantsNCT06541639
What this trial is testing

EVM16 Injection as a Single and Combination With Tislelizumab in Solid Tumors

Who this might be right for
Advanced or Recurrent Solid Tumors
Peking University 78
Early research (Phase 1)Active Not RecruitingNCT03889795
What this trial is testing

Phase IB Metformin, Digoxin, Simvastatin in Solid Tumors

Who this might be right for
Advanced Pancreatic CancerAdvanced Solid Tumor
Danae Hamouda, MD 15
Early research (Phase 1)Study completedNCT01791595
What this trial is testing

A Phase I Trial of AZD3965 in Patients With Advanced Cancer

Who this might be right for
Adult Solid TumorDiffuse Large B Cell LymphomaBurkitt Lymphoma
Cancer Research UK 53
Early research (Phase 1)Study completedNCT00437372
What this trial is testing

Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer Patients

Who this might be right for
CancerHead and Neck CancerPelvic Cancer+2 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 39
Early research (Phase 1)Study completedNCT02916095
What this trial is testing

Kanitinib in Treating Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumors
Beijing Konruns Pharmaceutical Co., Ltd. 9
Testing effectiveness (Phase 2)Ended earlyNCT00910039
What this trial is testing

Sunitinib Malate After Stereotactic Radiosurgery in Treating Patients With Newly Diagnosed Brain Metastases

Who this might be right for
Cognitive/Functional EffectsMetastatic CancerUnspecified Adult Solid Tumor, Protocol Specific
Case Comprehensive Cancer Center 14
Early research (Phase 1)Study completedNCT02182206
What this trial is testing

An Dose Escalation Study of Treatment With BIBF 1120 in Patients With Advanced Solid Tumours

Who this might be right for
Tumors
Boehringer Ingelheim 50
Early research (Phase 1)Study completedNCT02273388
What this trial is testing

BI 6727 Administered Intravenously Every 3 Weeks in Patients With Solid Tumours

Who this might be right for
Neoplasms
Boehringer Ingelheim 65
Early research (Phase 1)Study completedNCT02025803
What this trial is testing

A Safety, Tolerability and Pharmacokinetic Study of TAS-114 in Combination With Capecitabine in Patients With Advanced Solid Tumors

Who this might be right for
Neoplasms
Taiho Oncology, Inc. 60
Early research (Phase 1)Looking for participantsNCT05005403
What this trial is testing

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

Who this might be right for
Non-Small Cell Lung CancerHead and Neck Squamous Cell CarcinomaMicro Satellite Stable Colorectal Cancer+4 more
AbbVie
Next Page
694